Please login to the form below

Not currently logged in
Email:
Password:

Healthwatch England appoints comms and policy directors

Claire Pimm joins from DH and Marc Bush joins from Scope

Healthwatch England, the body to give patients and the general public a voice in the way health and social care services are run, has appointed two new directors to its senior team.

Claire Pimm moves from the Department of Health (DH) to become director of communications and engagement and Dr Marc Bush leaves disability charity Scope to take up the role of director of policy and intelligence.

They join a senior team headed by Dr Katherine Rake, who was appointed chief executive in December 2012, shortly after the body was formed as part of major reforms to the healthcare system in England.

Both new appointments have experience across the UK healthcare industry, with Pimm's most recent serving as head of brand management at the DH, holding responsibility for both the NHS and DH brands.

Previous roles include senior communications experience in the charity sector as head of communications at Bliss to support premature babies and head of communication at mental health charity Mind.

March Bush, Healthwatch EnglandDr Bush (pictured right) was head of research and public policy at Scope, having previously served as senior public policy adviser on children and youth policy.

Commenting on the appointments Dr Rake said: “I am delighted to have in place these two pivotal roles to drive the communications and engagement strategic direction of Healthwatch England into its next phase.

“Claire and Marc both bring with them a wealth of experience of health and social care issues and I am really excited that they will be joining the team.”

20th June 2013

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics